Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Observer-blind, Placebo-controlled Adaptive Clinical Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine With Alum Adjuvant in Adults of 18 to 65 Years of Age

NCT07743008 is registered in ClinicalTrials.gov with InventVacc Biologicals Inc. as lead sponsor.

NCT NCT07743008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Observer-blind, Placebo-controlled Adaptive Clinical Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine With Alum Adjuvant in Adults of 18 to 65 Years of Age
Lead sponsor
InventVacc Biologicals Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 29, 2026
Completion date
February 3, 2027
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilus influenzae, haemophilus influenzae type a